Human Normal Immunoglobulin (SCIG)
A. Replacement therapy in adults and children in primary immunodeficiency syndromes such as:
B. Replacement therapy in secondary immunodeficiencies (SID) in patients with severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l.
C. Immunomodulatory therapy:
Solution for subcutaneous injection, Vial, 200 mg/1mL, 5mL
|Rout of Administration||
• Do not store above 25 °C.
CSL Behring AG
|Country of Origin||